Table 3.
Effect of FHPp (250 mg/kg) on total and differential circulating leukocytes.
| Parameters | Group | ||
|---|---|---|---|
| AIA control | AIA + Tween | AIA + FHPp | |
| Day zero | |||
| TL | 11937 ± 323 | 11950 ± 204 | 11978 ± 508 |
| MN | 9821 ± 328 | 9890 ± 233 | 9793 ± 454 |
| PMN | 2116 ± 158 | 2060 ± 132 | 2185 ± 157 |
| 21° day | |||
| TL | 51867 ± 3407 | 45900 ± 1088 | 37429 ± 2373a |
| MN | 42412 ± 1940 | 36787 ± 370 | 29681 ± 1884a |
| PMN | 9455 ± 1653 | 9113 ± 973 | 7748 ± 650 |
The data are expressed as mean ± S.E.M. (n = 5). TL: total leukocyte; MN: mononuclear cells; PMN: polymorphonuclear cells; the determination of the number of cells was performed on day zero (before the injection of CFA in the left hind paw) and on day 21 after induction of arthritis. a P < 0.01 compared to the AIA control group. One-way ANOVA post hoc Tukey test.